Evidence map›Paper›PMID 25863248›Full record

ArticleCell metabolism2015

miR-222 is necessary for exercise-induced cardiac growth and protects against pathological cardiac remodeling.

Xiaojun Liu, Junjie Xiao, Han Zhu, Xin Wei, Colin Platt, Federico Damilano, Chunyang Xiao, Vassilios Bezzerides, Pontus Boström, Lin Che and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell metabolism, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 249 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
249citing papers in PubMed, 5 pooled it
24.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

249 citing papers in PubMed, 5 syntheses or guidelines pooled it, 388 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Review
  8. Are RNA Therapies a Solid Foundation or a Frontier Yet to Be Conquered?International journal of molecular sciences · 2026
    Review
  9. Exercise-induced cardiac hypertrophy: cellular and molecular mechanisms of cardiac adaptation following physical activity.Postepy w kardiologii interwencyjnej = Advances in interventional cardiology · 2026
    Review
  10. Article
  11. Review
  12. CCR2Frontiers in pharmacology · 2026
    Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. TargetingJournal of the American Heart Association · 2025
    Article

189 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 3 countries.

Xiaojun LiuCardiovascular Division of the Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA.
Junjie XiaoRegeneration Lab and Experimental Center of Life Sciences, School of Life Science, Shanghai University, Shanghai 200444, China.
Han ZhuCardiovascular Division of the Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA.
Xin WeiCardiovascular Division of the Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA.
Colin PlattCardiovascular Division of the Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA.
Federico DamilanoCardiovascular Division of the Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA.
Chunyang XiaoCardiovascular Division of the Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA.
Vassilios BezzeridesCardiovascular Division of the Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA; Cardiovascular Department of Boston Children's Hospital and Harvard Medical School, Boston, MA 02215, USA.
Pontus BoströmDepartment of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden.
Lin CheTongji Hospital, Tongji University School of Medicine, Shanghai 200065, China.
Chunxiang ZhangRush Medical College, Rush University, Chicago, IL 60612, USA.
Bruce M SpiegelmanDana-Farber Cancer Institute and Harvard Medical School, Boston, MA, 02115, USA.
Anthony RosenzweigCardiovascular Division of the Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA; Massachusetts General Hospital Cardiovascular Division and Harvard Medical School, Boston, MA 02115, USA. Electronic address: arosenzweig@partners.org.
Beth Israel Deaconess Medical Center · USBoston Children's Hospital · USHarvard University · USKarolinska Institutet · SERush University · USShanghai University · CNTongji University · CN

Funding

Molecular, Cellular, & Developmental Dynamics PhD ProgramT32GM007226 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI VAN VACTOR, DAVID L. · 1985 to 2021
$14.4M
RESEARCH METHODS IN PEDIATRICS HEART DISEASET32HL007572 · NHLBI · CHILDREN'S HOSPITAL BOSTON · PI Sarah D DE FERRANTI, Jane W. Newburger · 1985 to 2026
$13.0M
Training Program in Cardiovascular ResearchT32HL007374 · NHLBI · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI MITTLEMAN, MURRAY A · 1985 to 2019
$7.9M
PGC-1 AND NUCLEAR RECEPTORS IN ADAPTIVE THERMOGENESISR01DK054477 · NIDDK · DANA-FARBER CANCER INSTITUTE · PI SPIEGELMAN, BRUCE M. · 1998 to 2016
$7.0M
Plasma miRNA predictors of adverse mechanical and electrical remodeling after MIUH3TR000901 · NCATS · MASSACHUSETTS GENERAL HOSPITAL · PI DAS, SAUMYA, KWONG, RAYMOND Y · 2015 to 2017
$3.2M
The role of C/EBPbeta and CITED4 in the heartR01HL110733 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI ROSENZWEIG, ANTHONY · 2011 to 2015
$2.1M
Does Exercise Induce Cardiomyogenesis?R01HL122987 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI ROSENZWEIG, ANTHONY · 2014 to 2018
$1.7M
Role of miR-222 in pathological hypertrophy and heart failureR01HL135886 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI ROSENZWEIG, ANTHONY · 2017 to 2020
$1.7M
Plasma miRNA predictors of adverse mechanical and electrical remodeling after MIUH2TR000901 · NCATS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI DAS, SAUMYA, KWONG, RAYMOND Y · 2013 to 2014
$1.1M
Micro-RNA regulation of the cardiac exercise responseR21HL114352 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI ROSENZWEIG, ANTHONY · 2013 to 2014
$474k
NCATS NIH HHS 1UH2TR000901NCATS NIH HHS UH2 TR000901NCATS NIH HHS UH3 TR000901NHLBI NIH HHS R01 HL110733NHLBI NIH HHS R01HL110733NHLBI NIH HHS R01 HL122987NHLBI NIH HHS R01 HL135886NHLBI NIH HHS R21 HL114352NHLBI NIH HHS R21HL114352NHLBI NIH HHS T32 HL007374NHLBI NIH HHS T32 HL007572NHLBI NIH HHS T32HL007572-27A1NHLBI NIH HHS T32HL073734NIDDK NIH HHS R01 DK054477NIGMS NIH HHS T32 GM007226NIGMS NIH HHS T32GM007226
6 · The paper itself

Abstract

Exercise induces physiological cardiac growth and protects the heart against pathological remodeling. Recent work suggests exercise also enhances the heart's capacity for repair, which could be important for regenerative therapies. While microRNAs are important in certain cardiac pathologies, less is known about their functional roles in exercise-induced cardiac phenotypes. We profiled cardiac microRNA expression in two distinct models of exercise and found microRNA-222 (miR-222) was upregulated in both. Downstream miR-222 targets modulating cardiomyocyte phenotypes were identified, including HIPK1 and HMBOX1. Inhibition of miR-222 in vivo completely blocked cardiac and cardiomyocyte growth in response to exercise while reducing markers of cardiomyocyte proliferation. Importantly, mice with inducible cardiomyocyte miR-222 expression were resistant to adverse cardiac remodeling and dysfunction after ischemic injury. These studies implicate miR-222 as necessary for exercise-induced cardiomyocyte growth and proliferation in the adult mammalian heart and show that it is sufficient to protect the heart against adverse remodeling.

Indexed as

Models, CardiovascularAdultAnimalsAtrial RemodelingCell EnlargementCell ProliferationEchocardiographyHeartHumansImmunohistochemistryMiceMicroRNAsMicroscopy, ConfocalMyocytes, CardiacPhysical Conditioning, AnimalRatsMicroRNAsMIRN222 microRNA, mouse

Identifiers

PMID25863248
PMCPMC4393846
OpenAlexW1999507007

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.